# DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population

Study · id `cardio:ct-nct01331707` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01331707](<https://clinicaltrials.gov/study/NCT01331707>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01331707

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1811 participants.

## Technical summary

Registry record NCT01331707. Randomized; single masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1811 participants (enrolled count; ClinicalTrials.gov record NCT01331707, source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01331707, source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)
- Primary completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01331707, source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01331707, source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT01331707, source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01331707-2015-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
- Acronym: DUTCH PEERS
- Condition: Acute Coronary Syndrome
- Condition: Angina Pectoris
- Condition: Angina, Unstable
- Condition: Myocardial Infarction
- Condition: Coronary Artery Disease
- Condition: Coronary Stenosis
- Condition: Coronary Restenosis
- Intervention (Device): Resolute Integrity (Zotarolimus-eluting stent)
- Intervention (Device): Promus Element (Everolimus-eluting stent)
- Lead sponsor: Foundation of Cardiovascular Research and Education Enschede
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial (`cardio:pubmed-24183564`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial (`cardio:pubmed-27264217`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial (`cardio:pubmed-28445871`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial (`cardio:pubmed-29519378`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ab9d42e35c230b82d2f25b77ab7ef54167cdb81373e7e78166b82bda1e5493b4
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
